Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Change in Acquisitions & Divestments: 2021-2024

Historic Change in Acquisitions & Divestments for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Dec 2024 value amounting to $344.0 million.

  • Amylyx Pharmaceuticals' Change in Acquisitions & Divestments fell 14.67% to $64.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.0 million, marking a year-over-year decrease of 41.21%. This contributed to the annual value of $344.0 million for FY2024, which is 12.72% down from last year.
  • Per Amylyx Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $344.0 million for FY2024, which was down 12.72% from $394.1 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $394.1 million in FY2023 and a low of $3.0 million during FY2021.
  • Its 3-year average for Change in Acquisitions & Divestments is $305.8 million, with a median of $344.0 million in 2024.
  • As far as peak fluctuations go, Amylyx Pharmaceuticals' Change in Acquisitions & Divestments surged by 5,880.37% in 2022, and later dropped by 12.72% in 2024.
  • Amylyx Pharmaceuticals' Change in Acquisitions & Divestments (Yearly) stood at $3.0 million in 2021, then skyrocketed by 5,880.37% to $179.4 million in 2022, then surged by 119.67% to $394.1 million in 2023, then declined by 12.72% to $344.0 million in 2024.